Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001829126-25-008290
Filing Date
2025-10-20
Accepted
2025-10-20 21:42:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 17999
  Complete submission text file 0001829126-25-008290.txt   19699
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Subject) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-83670 | Film No.: 251405259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 600 MONTGOMERY STREET, 42ND FLOOR SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, 42ND FLOOR SAN FRANCISCO CA 94111 (628) 233-0357
Framework Ventures IV L.P. (Filed by) CIK: 0002028474 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A